Comment on "The impact of drug eluting stents on the co-release of interleukin-6 in patients with stable angina". [PDF]
Daungsupawong H, Wiwanitkit V.
europepmc +1 more source
Is There an Advantage of Ultrathin-Strut Drug-Eluting Stents over Second- and Third-Generation Drug-Eluting Stents? [PDF]
Gherasie FA, Valentin C, Busnatu SS.
europepmc +1 more source
A risk prediction nomogram for in-stent restenosis in patients with coronary heart disease: first exploratory analysis based on the substrate materials of drug-eluting stents. [PDF]
Zhao Z +9 more
europepmc +1 more source
Drug Coated Balloons Versus Drug-Eluting Stents in Patients With De Novo Coronary Artery Disease. [PDF]
O'Callaghan D +9 more
europepmc +1 more source
Drug-Coated Balloons Versus Drug-Eluting Stents for Large Vessel Coronary Artery Disease: A Meta-Analysis. [PDF]
Zeng J +5 more
europepmc +1 more source
Dedicated drug-eluting stents versus bare-metal stents for vertebral artery origin stenosis: a real-world single-center experience. [PDF]
Sun X +5 more
europepmc +1 more source
Durable versus biodegradable polymer drug-eluting stents in all-comers. [PDF]
Witzig T +6 more
europepmc +1 more source
Safety, efficacy, OCT-assessed vascular healing and angiographic outcomes of polymer-free versus biodegradable-polymer drug-eluting stents in patients undergoing percutaneous coronary intervention: a systematic review and meta-analysis. [PDF]
Abouelenien MM +3 more
europepmc +1 more source
Short dual antiplatelet therapy after PCI with Resolute Onyx drug-eluting stents in high bleeding risk patients: One-year outcomes from a South Asian cohort. [PDF]
Jariwala P +3 more
europepmc +1 more source
Bavry, Anthony A., Park, Ki
openaire +1 more source

